Walgreens Rite Aid Buyout: Investors Must Read Between The Lines! (RAD) (WBA)

The Walgreens Rite Aid buyout terms have changed, and RAD stock owners must consider there is more to this story with WBA.

Posted in Editor's Pick, Healthcare & Biotech, Members, Mergers & Acquisitions, Timely Analysis | Tagged , , , , | 2 Comments

Walgreens Rite Aid Buyout: Don’t Make This Huge Mistake (WBA) (RAD)

The NY Post has proven itself wrong throughout the Walgreens Rite Aid buyout. RAD stock and WBA stock owners can’t read too much into latest report.

Posted in Editor's Pick, Healthcare & Biotech, Members, Mergers & Acquisitions, Timely Analysis | Tagged , , , | Leave a comment

Why Walgreens Will Extend Its Rite Aid Buyout Offer (WBA) (RAD)

Trump’s FTC will ultimately review Walgreen Boots Alliance’s Rite Aid buyout offer, because WBA will extend the deadline to buy RAD.

Posted in Healthcare & Biotech, Members, Mergers & Acquisitions | Tagged , , , | Leave a comment

How Low Can RAD Stock & FRED Stock Go?

Why RAD stock and FRED stock will & can go much lower if the Walgreens Rite Aid merger is blocked. However, there is light at the end of the tunnel for RAD.

Posted in Editor's Pick, Members, Mergers & Acquisitions, Timely Analysis | Tagged , , , , | Leave a comment

What Now After FRED, WBA, & RAD Stock Fall With FTC’s Walgreens Rite Aid Merger Decision?

Reportedly, the Walgreens Rite Aid merger is a no go. Here’s how investors should play WBA stock, FRED stock, and RAD stock on the news.

Posted in Editor's Pick, Members, Mergers & Acquisitions, Timely Analysis | Tagged , , , , , | 1 Comment

While I Finally Sold RAD Stock & Bought WBA Stock Ahead of Walgreens Rite Aid Merger

After owning RAD stock since $1.23 and being overly bullish in favor of the Walgreens Rite Aid merger, I finally divested the stake and moved to WBA stock.

Posted in Healthcare & Biotech, Hot Stocks, Members, Mergers & Acquisitions | Tagged , , , | 4 Comments

Thoughts on RAD Stock’s Drop from $8.60 to $8.39 Despite Inevitable Rite Aid Buyout

RAD stock is about equal risk to cash and will significantly outperform stocks in early 2017. That makes Rite Aid stock’s $0.20 loss very attractive.

Posted in Healthcare & Biotech, Members, Mergers & Acquisitions | Tagged , , , , | Leave a comment